✦ LIBER ✦

A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours

✍ Scribed by Silke Gillessen; Ulrike S. Gnad-Vogt; Elisa Gallerani; Joachim Beck; Cristiana Sessa; Aurelius Omlin; Maria R. Mattiacci; Bernd Liedert; Daniel Kramer; Julien Laurent; Daniel E. Speiser; Roger Stupp

Book ID: 119233337
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 400 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.07.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1245 POSTER Phase I Dose-escalation Stud

1245 POSTER Phase I Dose-escalation Study of the Oral Selective C-Met Inhibitor EMD 1204831 in Patients With Advanced Solid Tumours

✍ G.S. Falchook; S. Fu; H.M. Amin; A.M. Tsimberdiou; D.S. Hong; A. Naing; M.B. Kle 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

1246 POSTER A Phase I Dose-escalation St

1246 POSTER A Phase I Dose-escalation Study of EMD 1214063, an Oral Selective C-Met Inhibitor, in Patients With Advanced Solid Tumours

✍ G.S. Falchook; S. Fu; H.M. Amin; S.A. Piha-Paul; D.S. Hong; A. Naing; M.B. Kleve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase I dose escalation study of telatin

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

✍ Strumberg, D; Schultheis, B; Adamietz, I A; Christensen, O; Buechert, M; Kraetzs 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB

Phase I dose-escalation study of F60008,

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours

✍ J.J.E.M. Kitzen; M.J.A. de Jonge; C.H.J. Lamers; F.A.L.M. Eskens; D. van der Bie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 495 KB

A phase I, dose-escalation study of the

A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma

✍ Hollebecque, A.; Deutsch, E.; Massard, C.; Gomez-Roca, C.; Bahleda, R.; Ribrag, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 445 KB

Phase I, dose-escalation study of AZD776

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

✍ Takashi Seto, Taito Esaki, Fumihiko Hirai… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 294 KB